Study to Examine the Effects of MultiStem in Ischemic Stroke

Not Recruiting

Trial ID: NCT01436487

Age - 18 Years-83 Years Condition - Stroke Gender - All Accepting Healthy Volunteers - No

Purpose

A study to examine the safety and potential effectiveness of the adult stem cell investigational product, MultiStem, in adults who have suffered an ischemic stroke. The hypothesis is that MultiStem will be safe and provide benefit following an ischemic stroke.

Official Title

Double-Blind, Randomized, Placebo-Controlled Phase 2 Safety and Efficacy Trial of MultiStem® in Adults With Ischemic Stroke

Stanford Investigator(s)

Nirali Vora
Nirali Vora

Clinical Professor, Neurology & Neurological Sciences

Eligibility


Inclusion Criteria:

   - Male or female subjects between 18 and 83 years of age (inclusive)

   - Clinical diagnosis of cortical cerebral ischemic stroke

   - Occurrence of a moderate to moderately severe stroke

Exclusion Criteria:

   - Presence of a lacunar or a brainstem infarct

   - Reduced level of consciousness

   - Major neurological event such as stroke or clinically significant head trauma within 6
   months of study

View More
View Less

Intervention(s):

biological: MultiStem

biological: Placebo

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Neil Schwartz
6507237193

©2024 Stanford Medicine